AUXLY CANNABIS GROUP INC (XLY.CA) Fundamental Analysis & Valuation

TSX:XLY • CA05335P1099

Current stock price

0.145 CAD
+0 (+3.57%)
Last:

This XLY.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. XLY.CA Profitability Analysis

1.1 Basic Checks

  • In the past year XLY was profitable.
  • In the past year XLY had a positive cash flow from operations.
  • In the past 5 years XLY reported 4 times negative net income.
  • In multiple years XLY reported negative operating cash flow during the last 5 years.
XLY.CA Yearly Net Income VS EBIT VS OCF VS FCFXLY.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50M -100M

1.2 Ratios

  • The Return On Assets of XLY (15.41%) is better than 96.77% of its industry peers.
  • XLY has a Return On Equity of 23.57%. This is amongst the best in the industry. XLY outperforms 96.77% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 8.32%, XLY belongs to the top of the industry, outperforming 90.32% of the companies in the same industry.
Industry RankSector Rank
ROA 15.41%
ROE 23.57%
ROIC 8.32%
ROA(3y)-2.61%
ROA(5y)-10.92%
ROE(3y)-25.92%
ROE(5y)-47.55%
ROIC(3y)N/A
ROIC(5y)N/A
XLY.CA Yearly ROA, ROE, ROICXLY.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100

1.3 Margins

  • XLY's Profit Margin of 27.63% is amongst the best of the industry. XLY outperforms 93.55% of its industry peers.
  • The Operating Margin of XLY (17.27%) is better than 77.42% of its industry peers.
  • Looking at the Gross Margin, with a value of 52.97%, XLY is in the better half of the industry, outperforming 77.42% of the companies in the same industry.
  • XLY's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 17.27%
PM (TTM) 27.63%
GM 52.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y21.67%
XLY.CA Yearly Profit, Operating, Gross MarginsXLY.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2K -4K -6K -8K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. XLY.CA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), XLY is destroying value.
  • XLY has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for XLY has been increased compared to 5 years ago.
  • Compared to 1 year ago, XLY has an improved debt to assets ratio.
XLY.CA Yearly Shares OutstandingXLY.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
XLY.CA Yearly Total Debt VS Total AssetsXLY.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

  • Based on the Altman-Z score of 0.34, we must say that XLY is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of XLY (0.34) is comparable to the rest of the industry.
  • XLY has a debt to FCF ratio of 2.43. This is a good value and a sign of high solvency as XLY would need 2.43 years to pay back of all of its debts.
  • XLY's Debt to FCF ratio of 2.43 is amongst the best of the industry. XLY outperforms 80.65% of its industry peers.
  • A Debt/Equity ratio of 0.28 indicates that XLY is not too dependend on debt financing.
  • XLY has a Debt to Equity ratio (0.28) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 2.43
Altman-Z 0.34
ROIC/WACC1
WACC8.33%
XLY.CA Yearly LT Debt VS Equity VS FCFXLY.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 2.20 indicates that XLY has no problem at all paying its short term obligations.
  • XLY has a Current ratio (2.20) which is comparable to the rest of the industry.
  • XLY has a Quick Ratio of 1.26. This is a normal value and indicates that XLY is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of XLY (1.26) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.2
Quick Ratio 1.26
XLY.CA Yearly Current Assets VS Current LiabilitesXLY.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. XLY.CA Growth Analysis

3.1 Past

  • XLY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 252.66%, which is quite impressive.
  • Looking at the last year, XLY shows a very strong growth in Revenue. The Revenue has grown by 23.83%.
  • Measured over the past years, XLY shows a very strong growth in Revenue. The Revenue has been growing by 26.52% on average per year.
EPS 1Y (TTM)252.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-82.35%
Revenue 1Y (TTM)23.83%
Revenue growth 3Y17.05%
Revenue growth 5Y26.52%
Sales Q2Q%11.97%

3.2 Future

  • Based on estimates for the next years, XLY will show a very negative growth in Earnings Per Share. The EPS will decrease by -50.82% on average per year.
  • The Revenue is expected to grow by 22.02% on average over the next years. This is a very strong growth
EPS Next Y-75.82%
EPS Next 2Y-50.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.84%
Revenue Next 2Y6.43%
Revenue Next 3Y28.06%
Revenue Next 5Y22.02%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
XLY.CA Yearly Revenue VS EstimatesXLY.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M
XLY.CA Yearly EPS VS EstimatesXLY.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.05 -0.1 -0.15

More info and screens

Find the best growth stocksShow best growing peers

6

4. XLY.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • XLY is valuated cheaply with a Price/Earnings ratio of 3.62.
  • Compared to the rest of the industry, the Price/Earnings ratio of XLY indicates a rather cheap valuation: XLY is cheaper than 90.32% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.89. XLY is valued rather cheaply when compared to this.
  • XLY is valuated correctly with a Price/Forward Earnings ratio of 14.36.
  • Based on the Price/Forward Earnings ratio, XLY is valued a bit cheaper than the industry average as 74.19% of the companies are valued more expensively.
  • XLY's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 38.50.
Industry RankSector Rank
PE 3.62
Fwd PE 14.36
XLY.CA Price Earnings VS Forward Price EarningsXLY.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • XLY's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. XLY is cheaper than 90.32% of the companies in the same industry.
  • 77.42% of the companies in the same industry are more expensive than XLY, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.6
EV/EBITDA 6.08
XLY.CA Per share dataXLY.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.02 0.04 0.06 0.08 0.1

4.3 Compensation for Growth

  • XLY has a very decent profitability rating, which may justify a higher PE ratio.
  • XLY's earnings are expected to decrease with -50.82% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-50.82%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. XLY.CA Dividend Analysis

5.1 Amount

  • XLY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

XLY.CA Fundamentals: All Metrics, Ratios and Statistics

AUXLY CANNABIS GROUP INC

TSX:XLY (4/17/2026, 7:00:00 PM)

0.145

+0 (+3.57%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-26
Earnings (Next)05-13
Inst Owners0.01%
Inst Owner ChangeN/A
Ins Owners5.7%
Ins Owner ChangeN/A
Market Cap203.73M
Revenue(TTM)151.48M
Net Income(TTM)41.85M
Analysts80
Price Target0.26 (79.31%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.79%
Revenue NY rev (3m)-0.79%
Valuation
Industry RankSector Rank
PE 3.62
Fwd PE 14.36
P/S 1.34
P/FCF 8.6
P/OCF 7.78
P/B 1.15
P/tB 1.36
EV/EBITDA 6.08
EPS(TTM)0.04
EY27.59%
EPS(NY)0.01
Fwd EY6.97%
FCF(TTM)0.02
FCFY11.62%
OCF(TTM)0.02
OCFY12.86%
SpS0.11
BVpS0.13
TBVpS0.11
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.337264 (132.6%)
Profitability
Industry RankSector Rank
ROA 15.41%
ROE 23.57%
ROCE 11.55%
ROIC 8.32%
ROICexc 9.71%
ROICexgc 11.36%
OM 17.27%
PM (TTM) 27.63%
GM 52.97%
FCFM 15.63%
ROA(3y)-2.61%
ROA(5y)-10.92%
ROE(3y)-25.92%
ROE(5y)-47.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y21.67%
F-Score6
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 2.43
Debt/EBITDA 1.3
Cap/Depr 21.98%
Cap/Sales 1.66%
Interest Coverage 250
Cash Conversion 69.65%
Profit Quality 56.57%
Current Ratio 2.2
Quick Ratio 1.26
Altman-Z 0.34
F-Score6
WACC8.33%
ROIC/WACC1
Cap/Depr(3y)21.06%
Cap/Depr(5y)21.69%
Cap/Sales(3y)1.84%
Cap/Sales(5y)3.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)252.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-82.35%
EPS Next Y-75.82%
EPS Next 2Y-50.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)23.83%
Revenue growth 3Y17.05%
Revenue growth 5Y26.52%
Sales Q2Q%11.97%
Revenue Next Year6.84%
Revenue Next 2Y6.43%
Revenue Next 3Y28.06%
Revenue Next 5Y22.02%
EBIT growth 1Y516.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year788.75%
EBIT Next 3Y116.21%
EBIT Next 5Y69.91%
FCF growth 1Y68.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y56.12%
OCF growth 3YN/A
OCF growth 5YN/A

AUXLY CANNABIS GROUP INC / XLY.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of AUXLY CANNABIS GROUP INC (XLY.CA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to XLY.CA.


Can you provide the valuation status for AUXLY CANNABIS GROUP INC?

ChartMill assigns a valuation rating of 6 / 10 to AUXLY CANNABIS GROUP INC (XLY.CA). This can be considered as Fairly Valued.


What is the profitability of XLY stock?

AUXLY CANNABIS GROUP INC (XLY.CA) has a profitability rating of 6 / 10.


How financially healthy is AUXLY CANNABIS GROUP INC?

The financial health rating of AUXLY CANNABIS GROUP INC (XLY.CA) is 5 / 10.


What is the expected EPS growth for AUXLY CANNABIS GROUP INC (XLY.CA) stock?

The Earnings per Share (EPS) of AUXLY CANNABIS GROUP INC (XLY.CA) is expected to decline by -75.82% in the next year.